FDA Adverse Event
Injury
Summary report: N
BLT Ø3.3MM NC, SLACTIVE® 14MM, TIZR, NTP
MDR report key: 13316276
·
Received January 21, 2022
Report
- Report Number
- 0001222315-2022-01319
- Event Type
- Injury
- Date Received
- January 21, 2022
- Date of Event
- November 10, 2021
- Report Date
- January 21, 2022
- Manufacturer
- INSTITUT STRAUMANN AG
- Product Code
- DZE
- UDI-DI
- 07630031706645
- Adverse Event
- Yes
- Report Source
- Distributor report
- Reporter Location
- WI, US
- Reporter Occupation
- DENTIST
- Health Professional
- Yes
Narratives
Description of Event or Problem · 0
THE CLINICIAN REPORTS THE IMPLANT WAS INSERTED 2021-08-18 IN ADA 9. ON 2021-11-10, NON-OSSEOINTEGRATION WAS VERIFIED. PATIENT PRESENTED WITH BONE TYPE III. THE DEVICE WAS FORWARDED TO THE MANUFACTURER. AT THE EVENT THE PATIENT EXPERIENCED: MOBILITY. NO FURTHER PATIENT COMPLICATIONS WERE REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 625731 | BLT Ø3.3MM NC, SLACTIVE® 14MM, TIZR, NTP | ENDOSSEOUS DENTAL IMPLANT | DZE | INSTITUT STRAUMANN AG | SLActive Roxolid BL | CWA51 | 07630031706645 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Female | Required Intervention |